1. Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
   Xiao Shen et al, 2023, Biomedicines CrossRef
2. Targeting CDK9: a promising therapeutic opportunity in prostate cancer
   Muhammed H Rahaman et al, 2016, Endocrine-Related Cancer CrossRef
3. Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion
   Xiaqiu Qiu et al, 2021, European Journal of Medicinal Chemistry CrossRef
4. Design, synthesis and biological evaluation of methylenehydrazine-1-carboxamide derivatives with (5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole scaffold: Novel potential CDK9 inhibitors
   Hongyu Hu et al, 2020, Bioorganic Chemistry CrossRef